A.R.T. Advisors’s Novavax NVAX Stock Holding History

A.R.T. Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-74,296	Closed	-$435K	–	1634
2019 Q2	$435K	Buy	+74,296	New	+$585K	0.02%	801
2019 Q1	–	Sell	-12,941	Closed	-$476K	–	1518
2018 Q4	$476K	Buy	+12,941	New	+$502K	0.03%	755
2018 Q3	–	Sell	-8,436	Closed	-$226K	–	1605
2018 Q2	$226K	Buy	+8,436	New	+$285K	0.01%	1197
2018 Q1	–	Sell	-6,636	Closed	-$164K	–	1681
2017 Q4	$164K	Sell	6,636 -2,177	-25%	-$53.1K	0.01%	1197
2017 Q3	$200K	Sell	8,813 -7,177	-45%	-$161K	0.01%	1136
2017 Q2	$367K	Sell	15,990 -11,185	-41%	-$219K	0.02%	937
2017 Q1	$695K	Buy	+27,175	New	+$747K	0.03%	685
2015 Q4	–	Sell	-38,595	Closed	-$5.46M	–	1644
2015 Q3	$5.46M	Buy	+38,595	New	+$8.65M	0.2%	119
2015 Q2	–	Sell	-11,624	Closed	-$1.92M	–	1641
2015 Q1	$1.92M	Buy	+11,624	New	+$1.89M	0.07%	407

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

A.R.T. Advisors's NVAX Position: Q3 2019 in Review

A.R.T. Advisors sold out of Novavax (NVAX) in Q3 2019, closing a stake of 74,296 shares — an estimated $435K sold.

A.R.T. Advisors first reported a position in NVAX in Q1 2015 and held it in 9 quarters. The position peaked at $5.46M in Q3 2015. 81 funds tracked by Wall St. Rank hold NVAX as of Q3 2019.

A.R.T. Advisors reported no remaining Novavax position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 74,296 Novavax shares in Q3 2019, an estimated $435K.
A.R.T. Advisors first reported a position in Novavax in Q1 2015 and held it in 9 quarters.
A.R.T. Advisors's Novavax position peaked at $5.46M in Q3 2015.
81 funds tracked by Wall St. Rank held Novavax as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.